Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
2
33%
Ph phase_4
3
50%
Ph not_applicable
1
17%

Phase Distribution

2

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
2(33.3%)
Phase 4Post-market surveillance
3(50.0%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(2)
Other(4)

Detailed Status

Completed2
Suspended2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (33.3%)
Phase 43 (50.0%)
N/A1 (16.7%)

Trials by Status

completed233%
suspended233%
unknown233%

Recent Activity

0 active trials
Showing 5 of 6
suspendedearly_phase_1

Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19

NCT04329572
suspendedearly_phase_1

Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19

NCT04348474
unknownnot_applicable

Nutritional Support and Prophylaxis Doses of Azithromycin for Pregnant Women - Mumta Pregnant Women Trial

NCT04012177
unknownphase_4

Azithromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis

NCT04454151
completedphase_4

Antenatal Azithromycin to Prevent Preterm Birth in Pregnant Women With Vaginal Cerclage

NCT04278937
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04329572Early Phase 1

Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19

Suspended
NCT04348474Early Phase 1

Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19

Suspended
NCT04012177Not Applicable

Nutritional Support and Prophylaxis Doses of Azithromycin for Pregnant Women - Mumta Pregnant Women Trial

Unknown
NCT04454151Phase 4

Azithromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis

Unknown
NCT04278937Phase 4

Antenatal Azithromycin to Prevent Preterm Birth in Pregnant Women With Vaginal Cerclage

Completed
NCT04062175Phase 4

Efficacy of Adding Azithromycin to Cephalosporin Before Cesarean Delivery

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6